Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
Clinical trial NCT05025488 · RECRUITING
Trial details
- NCT number
- NCT05025488
- Sponsor
- Marina Kremyanskaya
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-04
- Primary completion
- 2027-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.